Ask VialBase
weight · loss

HGH Fragment 176-191

FDA: research-only

HGH Frag 176-191 is a modified fragment of human growth hormone containing only the amino acid sequence responsible for its lipolytic (fat-burning) action, without the full range of GH effects. It selectively targets fat loss without affecting blood sugar or growth pathways. Modified form of HGH that includes only the amino acid sequence (positions 176-191) responsible for lipolytic action. Selectively activates fat breakdown without the anabolic or growth effects of full HGH. Does not raise IGF-1 levels, making it a targeted fat-loss tool. Related to AOD-9604, which is a stabilized version of this fragment. - Targeted fat loss without full

This content is for educational and research purposes only. VialBase does not provide medical advice. Consult a healthcare professional before using any peptide.

Molecular weight —
Half-life —
CAS number —
Route —
02

Sourcing

Current prices

Updated today

5mg

Only vendor stocking this size on the VialBase roster.

Stocks this compound Third-party tested Public COAs

VialBase may earn a commission on purchases through partner links — never at additional cost to you. Full disclosure.

What bloodwork do I need?

Reference ranges are general guidelines. Consult your physician for interpretation.

PRE-CYCLE
  • Fasting Glucose
  • Fasting Insulin
  • CMP
  • CBC
  • Lipid Panel
DURING CYCLE
  • Fasting Glucose
  • Fasting Insulin
POST-CYCLE
  • Fasting Glucose
  • Lipid Panel
Safety & Regulatory Status
FDA STATUS research-only

Regulatory status for HGH Fragment 176-191 may change. Verify current status with your jurisdiction before use. This is not legal or medical advice.